-+ 0.00%
-+ 0.00%
-+ 0.00%

Integra LifeSciences extends $150 million receivables facility maturity to 2029

PUBT·04/15/2026 20:24:57
Listen to the news
Integra LifeSciences extends $150 million receivables facility maturity to 2029
  • Integra LifeSciences entered April 10, 2026 amendments to its $150 million accounts receivable securitization facility with PNC Bank and Bank of Nova Scotia.
  • Amendment extends scheduled termination date of A/R Facility to April 10, 2029.
  • Updated terms revise customary representations and covenants under receivables financing agreement and purchase and sale agreement.
  • Changes also adjust customary concentration limits for receivables included in facility.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000917520-26-000019), on April 15, 2026, and is solely responsible for the information contained therein.